Patient hydration system with abnormal condition sensing

Details Patient hydration system with abnormal condition sensing Patient hydration system with abnormal condition sensing

2006-04-21

2010-11-23

Sirmons, Kevin C (Department: 3767)

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

C604S067000, C604S031000

Reexamination Certificate

active

07837667

ABSTRACT:
A patient hydration system and method wherein hydration fluid is administered to a patient and the patient's urine output is measured either by weight or some other suitable way. A controller is responsive to the patient's urine output measurement and configured to control the infusion rate to hydrate the patient based on the patient's urine output. The controller also detects abnormal patient urine output measurements and initiates corrective action in response.

REFERENCES:
patent: 3954010 (1976-05-01), Hilblom
patent: 4132644 (1979-01-01), Kolberg
patent: 4146029 (1979-03-01), Ellinwood, Jr.
patent: 4204957 (1980-05-01), Weickhardt
patent: 4216462 (1980-08-01), McGrath et al.
patent: 4229299 (1980-10-01), Savitz et al.
patent: 4261360 (1981-04-01), Perez
patent: 4275726 (1981-06-01), Schael
patent: 4291692 (1981-09-01), Bowman et al.
patent: 4343316 (1982-08-01), Jespersen
patent: 4448207 (1984-05-01), Parrish
patent: 4449538 (1984-05-01), Corbitt et al.
patent: 4504263 (1985-03-01), Steuer et al.
patent: 4658834 (1987-04-01), Blankenship et al.
patent: 4712567 (1987-12-01), Gille et al.
patent: 4728433 (1988-03-01), Buck et al.
patent: 4813925 (1989-03-01), Anderson, Jr. et al.
patent: 4923598 (1990-05-01), Schal
patent: 4994026 (1991-02-01), Fecondini
patent: 5098379 (1992-03-01), Conway et al.
patent: 5176148 (1993-01-01), Wiest et al.
patent: 5207642 (1993-05-01), Orkin et al.
patent: 5722947 (1998-03-01), Jeppsson et al.
patent: 5769087 (1998-06-01), Westphal et al.
patent: 5814009 (1998-09-01), Wheatman
patent: 5891051 (1999-04-01), Han et al.
patent: 5910252 (1999-06-01), Truitt et al.
patent: 5916153 (1999-06-01), Rhea, Jr.
patent: 5916195 (1999-06-01), Eshel et al.
patent: 5981051 (1999-11-01), Motegi et al.
patent: 6010454 (2000-01-01), Arieff et al.
patent: 6171253 (2001-01-01), Bullister et al.
patent: 6231551 (2001-05-01), Barbut
patent: 6272930 (2001-08-01), Crozafon et al.
patent: 6514226 (2003-02-01), Levin et al.
patent: 6537244 (2003-03-01), Paukovits et al.
patent: 6554791 (2003-04-01), Cartledge et al.
patent: 6640649 (2003-11-01), Paz et al.
patent: 6740072 (2004-05-01), Starkweather et al.
patent: 6752779 (2004-06-01), Paukovits et al.
patent: 6796960 (2004-09-01), Cioanta et al.
patent: 6827702 (2004-12-01), Lebel et al.
patent: 6942637 (2005-09-01), Cartledge et al.
patent: 7029456 (2006-04-01), Ware et al.
patent: 7044002 (2006-05-01), Ericson et al.
patent: 7137964 (2006-11-01), Flaherty
patent: 7278983 (2007-10-01), Ireland et al.
patent: 2002/0025597 (2002-02-01), Matsuda
patent: 2002/0072647 (2002-06-01), Shock et al.
patent: 2002/0107536 (2002-08-01), Hussein
patent: 2002/0151834 (2002-10-01), Utterberg
patent: 2002/0161314 (2002-10-01), Sarajarvi
patent: 2003/0048185 (2003-03-01), Citrebaum et al.
patent: 2003/0048432 (2003-03-01), Jeng et al.
patent: 2003/0114786 (2003-06-01), Hiller et al.
patent: 2004/0025597 (2004-02-01), Ericson et al.
patent: 2004/0059295 (2004-03-01), Cartledge et al.
patent: 2004/0081585 (2004-04-01), Reid
patent: 2004/0087894 (2004-05-01), Flaherty
patent: 2004/0122353 (2004-06-01), Shahmirian et al.
patent: 2004/0163655 (2004-08-01), Gelfand et al.
patent: 2004/0167415 (2004-08-01), Gelfand et al.
patent: 2004/0167464 (2004-08-01), Ireland et al.
patent: 2004/0176703 (2004-09-01), Christensen et al.
patent: 2004/0193328 (2004-09-01), Zaitsu et al.
patent: 2004/0243075 (2004-12-01), Harvie
patent: 2005/0027254 (2005-02-01), Vasko
patent: 2005/0065464 (2005-03-01), Talbot et al.
patent: 2006/0052764 (2006-03-01), Gelfand et al.
patent: 2006/0064053 (2006-03-01), Bollish et al.
patent: 2006/0184084 (2006-08-01), Ware et al.
patent: 2006/0253064 (2006-11-01), Gelfand et al.
patent: 2006/0270971 (2006-11-01), Gelfand et al.
patent: 2007/0088333 (2007-04-01), Levin et al.
patent: 2008/0027409 (2008-01-01), Rudko et al.
patent: 2008/0033394 (2008-02-01), Gelfand et al.
patent: 2008/0171966 (2008-07-01), Rudko et al.
patent: 2008/0221512 (2008-09-01), Da Silva et al.
patent: 0258690 (1988-03-01), None
patent: WO 2006/041496 (2006-04-01), None
U.S. Appl. No. 11/580,534, Rudko et al., filed Oct. 13, 2006.
Solomon R., Werner C, Mann D. et al. “Effects of Saline, Mannitol, and Furosemide to Prevent Acute Decreases in Renal Function Induced by Radiocontrast Agents”, N Engl J Med, 1994; 331:1416-1420.
Weinstein J.M., Heyman S., Brezis M. “Potential Deleterious Effect of Furosemide in Radiocontrast Nephropathy”, Nephron 1992; 62:413-415.
Wakelkamp et al., “The Influence of Drug Input Rate on the Development of Tolerance to Furosemide”, Br J Clin. Pharmacol. 1998; 46: 479-487.
Stevens et al., “A Prospective Randomized Trial of Prevention Measures in Patients at High Risk for Contrast Nephropathy, Results of the Prince. Study”, JACC vol. 33, No. 2, 1999 Feb. 1999:403-11.
U.S. Appl. No. 11/408,851, Gelfand et al., filed Apr. 21, 2006.
U.S. Appl. No. 11/409,171, Gelfand et al., filed Apr. 21, 2006.
Rosamilia et al.,Electromotive Drug Administration of Lidocaine and Dexamethasone Followed by Cystodistension in Women With Interstitial Cystitis, International Urogynecological Journal Pelvic Floor Dysfunction 1997; 8(3): 142-5.
James M. Gloor and Vincente E.,Reflux and Obstructive Nephropathy, Atlas of Diseases of the Kidney, on-line edition, vol. Two, Section I, Ch. 8, pp. 8.1-8.25 (date unknown).
Lelarge et al., “Acute Unilateral Renal Failure and Contralateral Ureteral Obstruction”, American Journal of Kidney Diseases, vol. XX, No. 3, Sep. 1992, pp. 286-8.
Doty et al., “Effect of Increased Renal Venous Pressure on Renal Function”, Journal of Trauma: Injury, Infection and Critical Care, vol. 47, No. 6, Dec. 1999, pp. 1000-1003.
Edelson et al., “Pharmacokinetics of Iohexol, a New Nonionic Radiocontrast Agent, in Humans”, Journal of Pharmaceutical Sciences, vol. 73, No. 7, Jul. 1984, pp. 993-995.
Hvistendahl et al., “Renal Hemodynamic Response to Gradated Ureter Obstruction in the Pig”, Nephron 1996; 74, pp. 168-174.
Pedersen et al., “Renal Water and Sodium Handling During Gradated Unilateral Ureter Obstruction”, Scand J Urol Nephrol 2002; 36, pp. 163-172.
Brezis et al., “Hypoxia of the Renal Medulla—its Implications for Disease” New England Journal of Medicine, vol. 322, No. 10, Mar. 9, 1995 pp. 647-655.
Heyman et al., “Pathophysiology of Radiocontrast Nephropathy: A Role for Medullary Hypoxia”, Investigative Radiology, vol. 34, No. 11, Nov. 1999, pp. 685-691.
Urexact ® 2000 System, mhtml:file://C:\Documents%20and%20Settings\bob\Local%20Settings\Temporary%20Int . . . (3 pages).
Bard Lubricath 3-Way Catheters, http://www.bardmedical.com/urology/cathtour/3way.html (1 page).
Foley Catheter Introduction, Foley Catheter, http://www.emedicinehealth.com/articles/11633-1.asp; http://www.emedicinehealth.com/articles/11633-8.asp (2 pages).
Gambro Acute Renal Failure, Prisma Machine, http://www.gambro.com/Page.asp?id=2446; http://www.gambro.com/upload/press—media—toolkit/download—images/Prisma.jpg (2 pages).
Angiometrix, The Metricath System, http://www.angiometrx.com/Metricath%20System.htm (1 page).
Merit Medical Systems, Inc. 2003 Annual Report; Balloon Inflation Devices & Pressure Monitoring Syringes; Transducers and Accessories, http://www.corporatewindow.com/annuals/mmsi03/10kpage5.html (3 pages).
Cardiovascular Mikro-Tip Pressure Transducer Catheters, http://www.millarinstruments.com/products/cardio/cardio—sngldual.html (5 pages).
Infusion Dynamics the Power Infuser, http://www.infusiondynamics.com/powerinfuser/ (2 pages).
Ultra-Low Profile Single Point Load Cell—S215, http://smdsensors.com/detail—pgs/s215.htm (2 pages).
Rihal et al.,Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention, Circulation, May 14, 2002, pp. 2259-2264.
Office Action of the Canadian Intellectual Property Office for Canadian Patent Application No. 2,579,829 mailed Jun. 13, 2008 (two (2) pages).
Written Opinion of t

Affiliated with

Also associated with

Rating

Patient hydration system with abnormal condition sensing does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Patient hydration system with abnormal condition sensing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Patient hydration system with abnormal condition sensing will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4227483